THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Gilead Sciences × PAHO lenacapavir access partnership
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Gilead Sciences and PAHO agreed to accelerate access to twice-yearly lenacapavir for HIV prevention across PAHO Member States in Latin America and the Caribbean.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- International, International
- Source checked
- September 28, 2026
FOLLOW THE STORY